AI assistant
Sending…
PFIZER INC — Director's Dealing 2008
Apr 4, 2008
29831_dirs_2008-04-03_0a198cc9-53cd-4241-be98-c2772b2fbb28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ENCYSIVE PHARMACEUTICALS INC (ENCY)
CIK: 0000887023
Period of Report: 2008-04-01
Reporting Person: PFIZER INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-04-01 | Common Stock | P | 175907 | $2.35 | Acquired | 70414776 | Indirect |
| 2008-04-02 | Common Stock | P | 6002 | $2.35 | Acquired | 70420778 | Indirect |
Footnotes
F1: Includes 8,473,574 shares that are subject to guaranteed delivery procedures.
F2: Includes 7,512,764 shares that are subject to guaranteed delivery procedures.
F3: Shares are directly owned by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer Inc.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31